Dr. Peter Metrakos

Dr. Peter Metrakos, MD CM, FACS, FRCSC is Associate Professor of Surgery and Associate Professor in Anatomy and Cell Biology McGill University.

As well he is Director of the Multi-Organ Transplant Program and Director of Hepatopancreatobiliary Surgery at the McGill University Health Center. He is also Director of the LD MacLean Surgical Research Laboratories.

Dr. Metrakos graduated in General Surgery from McGill University Faculty of Medicine where he also completed a 3 year Basic Science Fellowship in the Department of Experimental Surgery focusing on the physiology of the pancreas and cellular transplantation. Additional Fellowships were carried out in London, Ontario for liver, kidney and small bowel transplantation and in Minnesota for whole organ pancreas and islet cell transplantation.

Dr. Metrakos runs a high volume colorectal cancer liver metastases service among other disciplines. His research interests include The Effect of Neoadjuvant Chemotherapy on Liver Metastases (Znajda et al, Journal of Gastrointestinal Surgery 2006) and Proprotein convertases in tumour progression and malignancy: novel targets in cancer (Khatib et al, American Journal of Pathology 2002), Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastases (Tzimas et al, BMC Cancer 2005). Dr. Metrakos also has a large experience with sandwich chemotherapy for colorectal liver metastases undergoing liver resection: The pathology of liver nodules after neoadjuvant chemotherapy is associated with outcomes for colorectal cancer metastases (Chan et al, AHPBA 2007)

As well, Dr. Metrakos research interests have resulted in a publication in the New England Journal of Medicine: SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. Furthermore, Dr. Metrakos has established a database and experience with a large number of patients diagnosed with Neuroendocrine Tumour Liver Metastases.

Click here to return to the list of Montreal Speakers